HCA Healthcare
(NYSE) HCA
HCA Healthcare Financials at a Glance
Market Cap
$96.68B
Revenue (TTM)
$76.39B
Net Income (TTM)
$6.79B
EPS (TTM)
$29.08
P/E Ratio
15.24
Dividend
$2.94
Beta (Volatility)
0.72 (Low)
Dividend
$2.94
Beta (Volatility)
0.72 (Low)
Price
$446.41
Volume
1,443,379.318
Open
$438.51
Price
$446.41
Volume
1,443,379.318
Open
$438.51
Previous Close
$432.46
Daily Range
$434.11 - $447.13
52-Week Range
$326.14 - $556.52
Dividend
$2.94
Beta (Volatility)
0.72 (Low)
Price
$446.41
Volume
1,443,379.318
Open
$438.51
Previous Close
$432.46
Daily Range
$434.11 - $447.13
52-Week Range
$326.14 - $556.52
HCA News
What Is the Fortune 100?
HCA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout HCA Healthcare
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
320,000
CEO
Samuel N. Hazen, MBA
Website
www.hcahealthcare.comHeadquarters
Nashville, TN 37203, US
HCA Financials
Key Financial Metrics (TTM)
Gross Margin
35%
Operating Margin
16%
Net Income Margin
9%
Return on Equity
0%
Return on Capital
16%
Return on Assets
7%
Earnings Yield
6.56%
Dividend Yield
0.01%
Payout Ratio
10.04%
Stock Overview
Market Cap
$96.68B
Shares Outstanding
223.57M
Volume
1.44M
Short Interest
0.00%
Avg. Volume
1.13M
Financials (TTM)
Gross Profit
$31.37B
Operating Income
$11.96B
EBITDA
$15.60B
Operating Cash Flow
$12.64B
Capital Expenditure
$4.94B
Free Cash Flow
$7.69B
Cash & ST Invst.
$1.04B
Total Debt
$50.20B
HCA Healthcare Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.11B
+4.3%
Gross Profit
$2.86B
-62.1%
Gross Margin
14.98%
N/A
Market Cap
$96.68B
N/A
Market Cap/Employee
$302.14K
N/A
Employees
320,000
N/A
Net Income
$1.62B
+0.6%
EBITDA
$3.79B
+1.6%
Quarterly Fundamentals
Net Cash
$48.91B
-7.8%
Accounts Receivable
$11.32B
+2.1%
Inventory
$1.68B
-6.3%
Long Term Debt
$41.31B
-3.7%
Short Term Debt
$8.53B
+142.5%
Return on Assets
7.19%
N/A
Return on Invested Capital
15.55%
N/A
Free Cash Flow
$895.00M
+35.6%
Operating Cash Flow
$2.01B
+22.0%